← Medical directoryActive ingredient
Bempedoic acid/ezetimibe
A fixed-dose combination of bempedoic acid and ezetimibe (Nustendi) for lowering LDL. Spain's Interministerial Pricing Committee proposed it for public funding on 24 July 2023.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.





